Literature DB >> 11737075

Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis.

S Katoh1, Y Matsubara, H Taniguchi, K Fukushima, H Mukae, J Kadota, S Matsukura, S Kohno.   

Abstract

Interleukin (IL)-8 may play an important role in neutrophil infiltration in the airways of patients with diffuse panbronchiolitis (DPB). Furthermore, alveolar macrophages could produce IL-8 subsequent to CD44-hyaluronic acid (HA) interaction. The purpose of this study was to evaluate the contribution of CD44 expressed on alveolar macrophages to the pathogenesis of DPB. We examined the concentration of soluble CD44 (sCD44) in bronchoalveolar lavage fluid (BALF) and CD44 expression on macrophages in BALF from patients with DPB before and after low-dose, long-term macrolide therapy. We also assessed the HA-binding ability of alveolar macrophages as a functional analysis of the CD44 molecule. The sCD44 concentration in BALF was significantly lower in patients with DPB than in healthy volunteers. Percentages of alveolar macrophages expressing low CD44 (CD44 low(+)) and HA-nonbinding alveolar macrophages were higher in patients with DPB compared with healthy volunteers. Furthermore, macrolide therapy normalized CD44 expression and HA-binding ability of macrophages in BALF from DPB patients. Our findings suggest that alveolar macrophage dysfunction could result from abnormalities of CD44 expression in patients with DPB and that these events could contribute to the pathogenesis of DPB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737075      PMCID: PMC1906232          DOI: 10.1046/j.1365-2249.2001.01699.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  CD44 and its interaction with extracellular matrix.

Authors:  J Lesley; R Hyman; P W Kincade
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

2.  Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis.

Authors:  H Mukae; M Hirota; S Kohno; K Komori; K Fukushima; K Hiratani; J Kadota; K Hara
Journal:  Am Rev Respir Dis       Date:  1993-09

3.  Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.

Authors:  Y Ichikawa; H Ninomiya; H Koga; M Tanaka; M Kinoshita; N Tokunaga; T Yano; K Oizumi
Journal:  Am Rev Respir Dis       Date:  1992-07

4.  [Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report].

Authors:  K Mikasa; M Sawaki; E Kita; M Konishi; K Maeda; K Hamada; S Takeuchi; T Masutani; R Sano; M Kunimatsu
Journal:  Kansenshogaku Zasshi       Date:  1992-08

5.  CD44 positive macrophages take up hyaluronan during lung development.

Authors:  C B Underhill; H A Nguyen; M Shizari; M Culty
Journal:  Dev Biol       Date:  1993-02       Impact factor: 3.582

6.  A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.

Authors:  J Kadota; O Sakito; S Kohno; H Sawa; H Mukae; H Oda; K Kawakami; K Fukushima; K Hiratani; K Hara
Journal:  Am Rev Respir Dis       Date:  1993-01

7.  [Roxithromycin treatment in patients with chronic lower respiratory tract disease--its clinical efficacy and effect on cytokine].

Authors:  J Kadota; O Sakito; S Kohno; K Abe; R Shirai; K Kawakami; K Iida; T Morikawa; S Kusano; K Hara
Journal:  Kansenshogaku Zasshi       Date:  1994-01

8.  Erythromycin promotes monocyte to macrophage differentiation.

Authors:  N Keicho; S Kudoh; H Yotsumoto; K S Akagawa
Journal:  J Antibiot (Tokyo)       Date:  1994-01       Impact factor: 2.649

9.  Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages.

Authors:  P W Noble; F R Lake; P M Henson; D W Riches
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation.

Authors:  R L Camp; A Scheynius; C Johansson; E Puré
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  6 in total

1.  In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression.

Authors:  Maria Cecilia G Marcondes; Matthew Poling; Debbie D Watry; DeShon Hall; Howard S Fox
Journal:  Cell Immunol       Date:  2008-08-03       Impact factor: 4.868

2.  Novel Circulating and Tissue Monocytes as Well as Macrophages in Pancreatitis and Recovery.

Authors:  Murli Manohar; Elaina K Jones; Samuel J S Rubin; Priyanka B Subrahmanyam; Gayathri Swaminathan; David Mikhail; Lawrence Bai; Gulshan Singh; Yi Wei; Vishal Sharma; Janet C Siebert; Holden T Maecker; Sohail Z Husain; Walter G Park; Stephen J Pandol; Aida Habtezion
Journal:  Gastroenterology       Date:  2021-08-25       Impact factor: 22.682

3.  Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis.

Authors:  M Yamamoto; W Matsuyama; K Oonakahara; M Watanabe; I Higashimoto; M Kawabata; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

4.  Alteration of the expression of CD44 [corrected] isoforms in oral epithelia and saliva from patients with oral lichen planus.

Authors:  Ponlatham Chaiyarit; Kobkan Thongprasom; Sajee Satayut; Kittipong Dhanuthai; Pornpan Piboonratanakit; Pensri Phothipakdee; Ajiravudh Subarnbhesaj; Supakit Limlertmongkol; Mantharop Chaimusig
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

Review 5.  The where, when, how, and why of hyaluronan binding by immune cells.

Authors:  Sally S M Lee-Sayer; Yifei Dong; Arif A Arif; Mia Olsson; Kelly L Brown; Pauline Johnson
Journal:  Front Immunol       Date:  2015-04-14       Impact factor: 7.561

6.  CD44 Loss Disrupts Lung Lipid Surfactant Homeostasis and Exacerbates Oxidized Lipid-Induced Lung Inflammation.

Authors:  Yifei Dong; Arif A Arif; Jian Guo; Zongyi Ha; Sally S M Lee-Sayer; Grace F T Poon; Manisha Dosanjh; Calvin D Roskelley; Tao Huan; Pauline Johnson
Journal:  Front Immunol       Date:  2020-01-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.